This segment serves pharmaceutical, biotechnology, government and industrial markets by providing temperature controlled products, laboratory consumables, chemical raw materials, bio banking, and comparator drug sourcing. The acquisition will allow Thermo Fisher to expand its clinical trials logistics and supply business, a new market the company has been building up over the last few years. Thermo Fisher will also be able to provide biologics development and manufacturing services to its biotechnology clients, a growing sector in the pharmaceutical industry.